Medicure Stock Performance

MPH Stock  CAD 1.12  0.16  12.50%   
The company secures a Beta (Market Risk) of -0.92, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Medicure are expected to decrease slowly. On the other hand, during market turmoil, Medicure is expected to outperform it slightly. At this point, Medicure has a negative expected return of -0.14%. Please make sure to verify Medicure's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Medicure performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Medicure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
Last Split Factor
1:15
Last Split Date
2012-11-02
1
MACD Signals Flash Warning for Poly Medicure Limited Stock - Trading Volume Surges Free Trading Signals to Sharpen Your Edge - Bollywood Helpline
12/16/2025
2
Poly Medicure Ltd Faces Bearish Momentum Amid Technical Downturn - MarketsMojo
01/08/2026
3
Poly Medicure Ltd is Rated Sell - Markets Mojo
01/19/2026
4
Poly Medicure Ltd Stock Falls to 52-Week Low of Rs.1257.6 - Markets Mojo
02/19/2026
  

Medicure Relative Risk vs. Return Landscape

If you would invest  134.00  in Medicure on December 5, 2025 and sell it today you would lose (22.00) from holding Medicure or give up 16.42% of portfolio value over 90 days. Medicure is currently producing negative expected returns and takes up 5.6926% volatility of returns over 90 trading days. Put another way, 51% of traded stocks are less volatile than Medicure, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Medicure is expected to under-perform the market. In addition to that, the company is 7.42 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.04 per unit of volatility.

Medicure Target Price Odds to finish over Current Price

The tendency of Medicure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.12 90 days 1.12 
about 79.88
Based on a normal probability distribution, the odds of Medicure to move above the current price in 90 days from now is about 79.88 (This Medicure probability density function shows the probability of Medicure Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Medicure has a beta of -0.92. This indicates Additionally Medicure has an alpha of 0.2285, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Medicure Price Density   
       Price  

Predictive Modules for Medicure

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medicure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.126.81
Details
Intrinsic
Valuation
LowRealHigh
0.050.956.64
Details
Naive
Forecast
LowNextHigh
0.021.196.88
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.13-0.1-0.07
Details

Medicure Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medicure is not an exception. The market had few large corrections towards the Medicure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medicure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medicure within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.23
β
Beta against Dow Jones-0.92
σ
Overall volatility
0.08
Ir
Information ratio 0.03

Medicure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medicure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medicure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Medicure generated a negative expected return over the last 90 days
Medicure has high historical volatility and very poor performance
Medicure may become a speculative penny stock
Medicure has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 21.91 M. Net Loss for the year was (1.04 M) with profit before overhead, payroll, taxes, and interest of 12.77 M.
About 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: When the Price of Talks, People Listen - Stock Traders Daily

Medicure Fundamentals Growth

Medicure Stock prices reflect investors' perceptions of the future prospects and financial health of Medicure, and Medicure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medicure Stock performance.

About Medicure Performance

Evaluating Medicure's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medicure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medicure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 156.23  148.42 
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.12)(0.11)
Return On Assets(0.03)(0.03)
Return On Equity(0.04)(0.05)

Things to note about Medicure performance evaluation

Checking the ongoing alerts about Medicure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medicure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Medicure generated a negative expected return over the last 90 days
Medicure has high historical volatility and very poor performance
Medicure may become a speculative penny stock
Medicure has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 21.91 M. Net Loss for the year was (1.04 M) with profit before overhead, payroll, taxes, and interest of 12.77 M.
About 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: When the Price of Talks, People Listen - Stock Traders Daily
Evaluating Medicure's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Medicure's stock performance include:
  • Analyzing Medicure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medicure's stock is overvalued or undervalued compared to its peers.
  • Examining Medicure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Medicure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medicure's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Medicure's stock. These opinions can provide insight into Medicure's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Medicure's stock performance is not an exact science, and many factors can impact Medicure's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.